Compared to TREM2-TAM, TREM2 + TAMs secrete lower levels of CXCL9 but higher levels of galactagogue lectin-1, which promotes PD-L1 overexpression in vascular endothelial cells, impedes CD8 + T cell recruitment, and fosters tumor growth [65]. The gene discussed is CD8A; the disease is neoplasm.